Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheri L Spunt

Showing results (81-90 of 165) with videos related to

Pageof 17
Sort By:
Pediatric Hematology and Oncology|May 14, 2009
Sperm cryopreservation practices among adolescent cancer patients at risk for infertilityJames L Klosky, Mary E Randolph, Fariba Navid, et al.
JCO Oncology Practice|February 17, 2023
International Survey of Pediatric Oncologists' Beliefs and Communication Practices Regarding Symptom Self-Monitoring by Childhood Cancer SurvivorsSarah N Webster, Sheri L Spunt, Sarah J Cunningham, et al.
Cancer|January 31, 2009
A phase 1/pilot study of radiofrequency ablation for the treatment of recurrent pediatric solid tumorsFredric A Hoffer, Najat C Daw, Xiaoping Xiong, et al.
Psycho-Oncology|November 2, 2023
The bodily threat monitoring scale: Development and preliminary validation in adult and childhood cancer survivorsLauren C Heathcote, Sarah N Webster, Nele Loecher, et al.
Journal of Cancer Survivorship : Research and Practice|September 8, 2012
Association of bone mineral density with incidental renal stone in long-term survivors of childhood acute lymphoblastic leukemiaPrasad L Gawade, Kirsten K Ness, Shelly Sharma, et al.
Cancer|June 15, 2007
Analysis of prognostic factors in ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital studiesCarlos Rodríguez-Galindo, Tiebin Liu, Matthew J Krasin, et al.
Pediatric Blood & Cancer|May 7, 2011
The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1/BRCA2 mutationsKasiani Myers, Stella M Davies, Richard E Harris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: a report from the soft tissue sarcoma committee of the children's oncology groupSheri L Spunt, Lynette M Smith, Frederick B Ruymann, et al.
Cancer|January 27, 2009
Phase 1 study of oxaliplatin and irinotecan in pediatric patients with refractory solid tumors: a children's oncology group studyLisa M McGregor, Sheri L Spunt, Wayne L Furman, et al.
Pediatric Blood & Cancer|February 19, 2013
Relevance of historical therapeutic approaches to the contemporary treatment of pediatric solid tumorsDaniel M Green, Larry E Kun, Katherine K Matthay, et al.
Pageof 17

Showing results (81-90 of 165) with videos related to

Sort By:
Pageof 17
Pediatric Hematology and Oncology|May 14, 2009
Sperm cryopreservation practices among adolescent cancer patients at risk for infertilityJames L Klosky, Mary E Randolph, Fariba Navid, et al.
JCO Oncology Practice|February 17, 2023
International Survey of Pediatric Oncologists' Beliefs and Communication Practices Regarding Symptom Self-Monitoring by Childhood Cancer SurvivorsSarah N Webster, Sheri L Spunt, Sarah J Cunningham, et al.
Cancer|January 31, 2009
A phase 1/pilot study of radiofrequency ablation for the treatment of recurrent pediatric solid tumorsFredric A Hoffer, Najat C Daw, Xiaoping Xiong, et al.
Psycho-Oncology|November 2, 2023
The bodily threat monitoring scale: Development and preliminary validation in adult and childhood cancer survivorsLauren C Heathcote, Sarah N Webster, Nele Loecher, et al.
Journal of Cancer Survivorship : Research and Practice|September 8, 2012
Association of bone mineral density with incidental renal stone in long-term survivors of childhood acute lymphoblastic leukemiaPrasad L Gawade, Kirsten K Ness, Shelly Sharma, et al.
Cancer|June 15, 2007
Analysis of prognostic factors in ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital studiesCarlos Rodríguez-Galindo, Tiebin Liu, Matthew J Krasin, et al.
Pediatric Blood & Cancer|May 7, 2011
The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1/BRCA2 mutationsKasiani Myers, Stella M Davies, Richard E Harris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: a report from the soft tissue sarcoma committee of the children's oncology groupSheri L Spunt, Lynette M Smith, Frederick B Ruymann, et al.
Cancer|January 27, 2009
Phase 1 study of oxaliplatin and irinotecan in pediatric patients with refractory solid tumors: a children's oncology group studyLisa M McGregor, Sheri L Spunt, Wayne L Furman, et al.
Pediatric Blood & Cancer|February 19, 2013
Relevance of historical therapeutic approaches to the contemporary treatment of pediatric solid tumorsDaniel M Green, Larry E Kun, Katherine K Matthay, et al.
Pageof 17